Designing the Most Cost-Effective Manufacturing Strategy for Allogeneic Cell-Based TherapiesDesigning the Most Cost-Effective Manufacturing Strategy for Allogeneic Cell-Based Therapies

Rapid progress is occurring in the field of stem cell therapy research, and increasing numbers of products will begin reaching the market in the near future. But new cell therapy treatments must fit into a competitive and highly regulated healthcare environment. Succeeding in that environment requires alignment between a company’s business model and its manufacturing strategy.

Read the full text of this article in the PDF (Login required).